These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28459461)

  • 41. Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.
    Mathew LK; Huangyang P; Mucaj V; Lee SS; Skuli N; Eisinger-Mathason TS; Biju K; Li B; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Simon MC
    Sci Signal; 2015 May; 8(375):ra42. PubMed ID: 25943352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
    Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
    Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
    Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.
    Lindberg OR; McKinney A; Engler JR; Koshkakaryan G; Gong H; Robinson AE; Ewald AJ; Huillard E; David James C; Molinaro AM; Shieh JT; Phillips JJ
    Oncotarget; 2016 Nov; 7(48):79101-79116. PubMed ID: 27738329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
    Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
    Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
    Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
    Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.
    Qi Z; Cai S; Cai J; Chen L; Yao Y; Chen L; Mao Y
    BMC Neurol; 2016 Dec; 16(1):248. PubMed ID: 27905892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs involved in the EGFR pathway in glioblastoma.
    Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
    Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.
    Li D; Wang Z; Chen Z; Lin L; Wang Y; Sailike D; Luo K; Du G; Xiang X; Jiafu GD
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):245-250. PubMed ID: 27815074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth.
    Wang YY; Sun G; Luo H; Wang XF; Lan FM; Yue X; Fu LS; Pu PY; Kang CS; Liu N; You YP
    CNS Neurosci Ther; 2012 Sep; 18(9):722-8. PubMed ID: 22709411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-340 suppresses glioblastoma multiforme.
    Huang D; Qiu S; Ge R; He L; Li M; Li Y; Peng Y
    Oncotarget; 2015 Apr; 6(11):9257-70. PubMed ID: 25831237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monocarboxylate Transporter 4 Regulates Glioblastoma Motility and Monocyte Binding Ability.
    Lai SW; Lin HJ; Liu YS; Yang LY; Lu DY
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32045997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
    J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
    Guo G; Narayan RN; Horton L; Patel TR; Habib AA
    Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
    Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
    Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.